Supplementary Table 5.
Features | Level | Hazard ratio (95% CI) | P-value |
---|---|---|---|
Metastatic sites | Bone | Ref | |
Lung | 1.022 (0.854–1.223) | 0.815 | |
Liver | 1.310 (1.047–1.640) | 0.018 | |
Brain | 1.877 (1.378–2.556) | <0.001 | |
Metastatic sites | Lung | Ref | |
Bone | 0.979 (0.818–1.171) | 0.815 | |
Brain | 1.837 (1.346–2.507) | <0.001 | |
Liver | 1.282 (1.021–1.610) | 0.032 | |
Metastatic sites | Liver | Ref | |
Lung | 0.780 (0.621–0.979) | 0.032 | |
Bone | 0.763 (0.610–0.955) | 0.018 | |
Brain | 1.432 (1.022–2.008) | 0.037 |